Verastem, Inc. (NASDAQ:VSTM) Q4 2025 Earnings Call Transcript March 4, 2026 Verastem, Inc. misses on earnings expectations. Reported EPS is $-0.5 EPS, expectations were $-0.49. Operator: Good ...
Pelvic organ prolapse (POP) represents a highly prevalent condition among women, particularly following childbirth and during aging, with recurrence rates following surgical intervention posing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results